期刊:Cancer Discovery [American Association for Cancer Research] 日期:2024-01-01
标识
DOI:10.1158/2159-8290.cd-nw2024-0100
摘要
Basic and translational research shows that a low-carbohydrate, high-fat ketogenic diet, which is rich in the metabolite β-hydroxybutyrate, can increase the proliferation of chimeric antigen receptor T-cell therapies and better suppress tumor growth. Scientists have launched a phase I study to test their findings in patients.